{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:56:34Z","timestamp":1791618994583,"version":"4.3.4"},"reference-count":46,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Considerable efforts have been carried out over the past 30 years to support patients with advanced cervical cancer. Throughout this time, Eastern European countries have been left aside from the decision-making groups on this matter, hence the absence of similar studies in this geographical area. In these countries, the quality of life (QoL) of patients with cervical cancer might be considered a \u201ccaprice\u201d, and the discomforts they encounter following pelvic exenteration for cervical cancer are often perceived as a \u201cnormal phenomenon\u201d. Methods: This study examined forty-seven patients submitted to pelvic exenteration followed up for nine years after the surgical intervention. The first objective of this study is to identify the prognostic factors that influence the overall survival (OS) of patients undergoing pelvic exenteration for FIGO stage IVA, recurrent or persistent cervical cancer after previous conclusive treatments. The second objective is to assess the QoL of the surviving patients using the QLQ-C30 and QLQ-CX24 standardized questionnaires. Results: The mean age of the participants was 54 years (range 36\u201367). At the time of the study, there were 25 living patients (53.2%), the 3-year OS was 61%, and the 5-year OS was 48.7%. Cox regression analysis recognized parameter invasion, pelvic lymph node metastases, positive resection margins, early postoperative complications, and infralevatorian pelvic exenteration as negative prognostic factors influencing the OS (p &lt; 0.05). Of the 25 survivors, 18 patients answered the QoL questionnaires. The cost of favorable survival has been translated into poor overall QoL, unsatisfactory functional, social, and symptom scores, a high prevalence of cervical cancer-specific symptoms such as lymphedema, peripheral neuropathy, severe menopausal symptoms, distorted body image, and lack of sexual desire. The lower scores are comparable to the only three studies available in the literature that assessed the QoL of patients undergoing pelvic exenteration precisely for cervical cancer. Conclusions: Despite its retrospective nature and some limitations, this paper, similar to other studies, shows a decent OS but with a marked adverse impact on QoL, suggesting the importance of adequate psycho-emotional and financial support for these patients following pelvic exenteration. This study also contributes to the current knowledge regarding advanced cervical cancer treatment, depicting survival, prognostic factors, and QoL of patients undergoing pelvic exenteration for cervical cancer in a reference center in Eastern Europe. Our study can provide a comparison for future prospective randomized trials needed to confirm these results.<\/jats:p>","DOI":"10.3390\/cancers14092346","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T21:23:27Z","timestamp":1652131407000},"page":"2346","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Long-Term Survival, Prognostic Factors, and Quality of Life of Patients Undergoing Pelvic Exenteration for Cervical Cancer"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2535-509X","authenticated-orcid":false,"given":"Mihai","family":"Stanca","sequence":"first","affiliation":[{"name":"First Obstetrics and Gynecology Clinic, University of Medicine, Pharmacy, Science and Technology \u201cG.E. Palade\u201d of T\u00e2rgu Mure\u0219, Gheorghe Marinescu Street, Number 38, 540142 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan Mihai","family":"C\u0103p\u00eelna","sequence":"additional","affiliation":[{"name":"First Obstetrics and Gynecology Clinic, University of Medicine, Pharmacy, Science and Technology \u201cG.E. Palade\u201d of T\u00e2rgu Mure\u0219, Gheorghe Marinescu Street, Number 38, 540142 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5661-2514","authenticated-orcid":false,"given":"Mihai Emil","family":"C\u0103p\u00eelna","sequence":"additional","affiliation":[{"name":"First Obstetrics and Gynecology Clinic, University of Medicine, Pharmacy, Science and Technology \u201cG.E. Palade\u201d of T\u00e2rgu Mure\u0219, Gheorghe Marinescu Street, Number 38, 540142 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO;2-A","article-title":"Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy","volume":"1","author":"Brunschwig","year":"1948","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12957-020-01997-3","article-title":"Analysis of long-term outcomes in 44 patients following pelvic exenteration due to cervical cancer","volume":"18","author":"Lewandowska","year":"2020","journal-title":"World J. Surg. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.suronc.2011.12.008","article-title":"Management of recurrent cervical cancer: A review of the literature","volume":"21","author":"Peiretti","year":"2012","journal-title":"Surg. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/IGC.0b013e3182a80aec","article-title":"Survival after curative pelvic exenteration for primary or recurrent cervical cancer: A retrospective multicentric study of 167 patients","volume":"24","author":"Chiantera","year":"2014","journal-title":"Int. J. Gynecol. Cancer  Off. J. Int. Gynecol. Cancer Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/IGC.0b013e318287a874","article-title":"Pelvic exenteration for recurrent gynecologic malignancy: A study of 28 consecutive patients at a single institution","volume":"23","author":"Nilsson","year":"2013","journal-title":"Int. J. Gynecol. Cancer  Off. J. Int. Gynecol. Cancer Soc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1477-7819-12-279","article-title":"Surgical results of pelvic exenteration in the treatment of gynecologic cancer","volume":"12","author":"Petruzziello","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/IGC.0b013e31824eb8cd","article-title":"Pelvic exenterations for gynecological malignancies: A study of 36 cases","volume":"22","author":"Kaur","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ygyno.2006.06.027","article-title":"Indications for primary and secondary exenterations in patients with cervical cancer","volume":"103","author":"Marnitz","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1470-2045(06)70903-2","article-title":"Pelvic exenteration for gynecological tumors: Achievements and unanswered questions","volume":"7","year":"2006","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00404-019-05154-4","article-title":"Pelvic exenteration as ultimate ratio for gynecologic cancers: Single-center analyses of 37 cases","volume":"300","author":"Ebner","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SLA.0b013e31828a0d22","article-title":"Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer","volume":"259","author":"Bhangu","year":"2014","journal-title":"Ann. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4103\/0366-6999.235111","article-title":"Pelvic Exenteration for Recurrent and Persistent Cervical Cancer","volume":"131","author":"Li","year":"2018","journal-title":"Chin. Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/cncr.22217","article-title":"The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24","volume":"107","author":"Greimel","year":"2006","journal-title":"Cancer"},{"key":"ref_15","first-page":"142","article-title":"Pelvic exenteration\u2014Our initial experience in 15 cases","volume":"36","author":"Moldovan","year":"2015","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_16","first-page":"263","article-title":"Anatomical variations of the obturator veins and their surgical implications","volume":"38","author":"Szabo","year":"2017","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ygyno.2006.05.044","article-title":"Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: Technique and review of the literature","volume":"103","author":"Sonoda","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.3802\/jgo.2018.29.e68","article-title":"The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer","volume":"29","author":"Jalloul","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1245\/s10434-012-2768-6","article-title":"Does histologic type correlate to outcome after pelvic exenteration for cervical and vaginal cancer?","volume":"20","author":"Baiocchi","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3802\/jgo.2012.23.4.242","article-title":"Pelvic exenteration for recurrent cervical cancer: Ten-year experience at national cancer center in Korea","volume":"23","author":"Yoo","year":"2012","journal-title":"J. Gynecol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/ijgc-00009577-200409000-00016","article-title":"Surgical resection of locally recurrent cervical cancer: A single institutional 70 patient series","volume":"14","author":"Moutardier","year":"2004","journal-title":"Int. J. Gynecol. Cancer  Off. J. Int. Gynecol. Cancer Soc."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Stanca, M., and C\u0103p\u00eelna, M.E. (2021). Prognostic Factors Associated with 5-Year Overall Survival in Cervical Cancer Patients Treated with Radical Hysterectomy Followed by Adjuvant Concurrent Chemoradiation Therapy at a Tertiary Care Center in Eastern Europe. Diagnostics, 11.","DOI":"10.3390\/diagnostics11030570"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Stanca, M., C\u0103p\u00eelna, D.M., Tr\u00e2mbi\u021ba\u0219, C., and C\u0103p\u00eelna, M.E. (2022). The Overall Quality of Life and Oncological Outcomes Following Radical Hysterectomy in Cervical Cancer Survivors Results from a Large Long-Term Single-Institution Study. Cancers, 14.","DOI":"10.3390\/cancers14020317"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/gyno.1996.4532","article-title":"Pelvic exenterations: Supralevator, infralevator, and with vulvectomy","volume":"64","author":"Magrina","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s10397-019-1055-y","article-title":"Pelvic exenteration in gynecologic cancer: Complications and oncological outcome","volume":"16","author":"Lago","year":"2019","journal-title":"Gynecol. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/ijgc-2020-001613","article-title":"Orthotopic continent urinary diversion (the Budapest pouch) in 10 steps","volume":"30","author":"Palfalvi","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/IGC.0000000000000435","article-title":"Pelvic exenteration in gynecologic cancer: La Paz university hospital experience","volume":"25","author":"Diestro","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ygyno.2013.02.024","article-title":"Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies","volume":"129","author":"Urh","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2019.02.002","article-title":"Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study","volume":"153","author":"Matsuo","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/SLA.0000000000003533","article-title":"Pelvic exenteration for advanced nonrectal pelvic malignancy","volume":"270","author":"Kelly","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00268-010-0637-7","article-title":"Pelvic Exenteration for Advanced and Recurrent Malignancy","volume":"34","author":"Zoucas","year":"2010","journal-title":"World J. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.21873\/invivo.11723","article-title":"Pelvic Exenteration for Locally Advanced and Relapsed Pelvic Malignancies\u2014An Analysis of 100 Cases","volume":"33","author":"Bacalbasa","year":"2019","journal-title":"Vivo"},{"key":"ref_35","first-page":"975","article-title":"Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review","volume":"41","author":"Sardain","year":"2015","journal-title":"Eur. J. Surg.Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s13193-018-0792-0","article-title":"Pelvic Exenteration Put into Therapeutical and Palliative Perspective: It Is Worth to Try","volume":"9","author":"Karmaniolou","year":"2018","journal-title":"Indian J. Surg. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2014.06.034","article-title":"Overall survival after pelvic exenteration for gynecologic malignancy","volume":"134","author":"Westin","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2011.03.003","article-title":"Pelvic exenteration in gynecologic oncology: A single institution study over 20 years","volume":"122","author":"Benn","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_39","unstructured":"European Society of Gynaecological Oncology (2018). Cervical Cancer Pocket Guidelines. Eur. Soc. Gynaecol. Oncol., 1\u201348. Available online: https:\/\/guidelines.esgo.org\/cervical-cancer\/guidelines\/recommendations\/."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/IGC.0000000000000612","article-title":"Quality of life in women after pelvic exenteration for gynecological malignancies: A multicentric study","volume":"28","author":"Dessole","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ygyno.2012.09.030","article-title":"A prospective study of quality of life in patients undergoing pelvic exenteration: Interim results","volume":"128","author":"Rezk","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/gyno.1997.4813","article-title":"Pelvic exenteration: Effects of surgery on quality of life and body image\u2014A prospective longitudinal study","volume":"66","author":"Hoffmann","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0277-9536(99)00050-7","article-title":"Clinical understanding and clinical implications of response shift","volume":"48","author":"Wilson","year":"1999","journal-title":"Soc. Sci. Med."},{"key":"ref_44","first-page":"5045","article-title":"Quality of Life and Sexuality of Patients after Treatment for Gynaecological Malignancies: Results of a Prospective Study in 55 Patients","volume":"32","author":"Pilger","year":"2012","journal-title":"Anticancer. Res."},{"key":"ref_45","first-page":"180","article-title":"Vaginoplasty with Acellular Dermal Matrix after Radical Resection for Carcinoma of the Uterine Cervix","volume":"32","author":"Wang","year":"2019","journal-title":"J. Investig. Surg. Off. J. Acad. Surg. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/s1677-5538.ibju.2020.0338","article-title":"Vaginoplasty tips and tricks","volume":"47","author":"Li","year":"2021","journal-title":"Int. Braz J Urol  Off. J. Braz. Soc. Urol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/9\/2346\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:08:26Z","timestamp":1760137706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/9\/2346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["cancers14092346"],"URL":"https:\/\/doi.org\/10.3390\/cancers14092346","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]}}}